1
|
Patel AA, Weber PC, Levi JR. The effect of tympanostomy tubes on otoacoustic emissions. Eur Arch Otorhinolaryngol 2024; 281:4635-4639. [PMID: 38698162 DOI: 10.1007/s00405-024-08656-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2024] [Accepted: 04/03/2024] [Indexed: 05/05/2024]
Abstract
PURPOSE Otoacoustic emissions (OAE) are a common screening tool to evaluate cochlear function. Middle ear dysfunction has been shown to impact results of otoacoustic emission testing, but there are limited data on the effect of tympanostomy tubes on OAE. The purpose of this study was to determine whether tympanostomy tube placement significantly improved OAE. METHODS A retrospective review of charts was completed for patients younger than 18 years old who underwent tympanostomy tube placement from January 1, 2018 to September 1, 2023 and had preoperative and postoperative OAE testing within 6 months of surgery. The primary variable was presence of OAE preoperatively and postoperatively. Chi-square analysis and t test were used for statistical analysis. RESULTS A total of 212 ears were examined from 111 pediatric patients who underwent tympanostomy tube placement during the study period. Presence of OAE at 3000, 4000, and 5000 Hz were all noted to significantly increase following tympanostomy tube placement, with OAE presence increasing from approximately 27.8% of the sample preoperatively to 95.3% postoperatively at 3000 and 4000 Hz. Patients who noted improvement had a significantly higher proportion of type B tympanogram preoperatively, compared to a higher proportion of type A tympanogram noted in patients who did not note improvement. CONCLUSION Tympanostomy tubes can significantly improve otoacoustic emissions in patients with middle ear dysfunction.
Collapse
Affiliation(s)
- Aneesh A Patel
- Department of Otolaryngology, Boston University Medical Center, 800 Harrison Ave, BCD Building, 5th Floor, Boston, MA, 02118, USA
- Boston University School of Medicine, 72 E Concord St, Boston, MA, 02118, USA
| | - Peter C Weber
- Department of Otolaryngology, Boston University Medical Center, 800 Harrison Ave, BCD Building, 5th Floor, Boston, MA, 02118, USA
- Boston University School of Medicine, 72 E Concord St, Boston, MA, 02118, USA
| | - Jessica R Levi
- Department of Otolaryngology, Boston University Medical Center, 800 Harrison Ave, BCD Building, 5th Floor, Boston, MA, 02118, USA.
- Boston University School of Medicine, 72 E Concord St, Boston, MA, 02118, USA.
| |
Collapse
|
2
|
Perdrizet J, Farkouh RA, Horn EK, Hayford K, Sings HL, Wasserman MD. The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines. Expert Rev Vaccines 2022; 21:499-511. [PMID: 35191368 DOI: 10.1080/14760584.2022.2040989] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
INTRODUCTION Otitis media (OM) is a common childhood infection. Pneumococcal conjugate vaccines (PCVs) prevent OM episodes, thereby reducing short- and long-term clinical, economic, humanistic, and societal consequences. Most economic evaluations of PCVs focus on direct health gains and cost savings from prevented acute episodes but do not fully account for the broader societal impacts of OM prevention. AREAS COVERED This review explores the broader burden of OM on children, caregivers, and society to better inform future economic evaluations of PCVs. EXPERT OPINION OM causes a substantial burden to society through long-term sequelae, productivity losses, reduced quality of life for children and caregivers, and contribution to antimicrobial resistance from inappropriate antibiotic use. The effect of PCVs on acute OM has been recognized globally, yet the broader impact has not been consistently quantified, studied, or communicated. Economic evaluations of PCVs must evolve to include broader effects for patients, caregivers, and society from OM prevention. Future PCVs with broader coverage may further reduce OM incidence and antimicrobial resistance, but optimal uptake will depend on increasing the recognition and use of novel frameworks that include broader benefits. Communicating the full value of PCVs to decision makers may result in wider access and positive societal returns.
Collapse
Affiliation(s)
- Johnna Perdrizet
- Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA
| | - Raymond A Farkouh
- Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA
| | - Emily K Horn
- Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA
| | - Kyla Hayford
- Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer, Inc., Toronto, Canada
| | - Heather L Sings
- Vaccines Medical Development and Scientific and Clinical Affairs, Pfizer, Inc., Collegeville, PA, USA
| | - Matt D Wasserman
- Health Economics and Outcomes Research, Pfizer Inc, New York, NY, USA
| |
Collapse
|
3
|
Laakso JT, Rissanen V, Ruotsalainen E, Korpi J, Laulajainen‐Hongisto A, Sivonen V, Sinkkonen ST. Severe acute otitis media and mastoiditis caused by group A beta-hemolytic streptococcus. Laryngoscope Investig Otolaryngol 2021; 6:1158-1166. [PMID: 34667861 PMCID: PMC8513450 DOI: 10.1002/lio2.659] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2021] [Revised: 08/25/2021] [Accepted: 08/28/2021] [Indexed: 11/15/2022] Open
Abstract
OBJECTIVE To describe the characteristics, diagnostics, treatment, and outcome of severe acute otitis media (AOM) and acute mastoiditis (AM) caused by group A beta-hemolytic streptococcus (GAS). STUDY DESIGN A retrospective cohort study. METHODS The yearly incidence of inpatient care-needing GAS AOM/AM patients in our hospital catchment area between 2002 and 2018 was investigated. A detailed analysis was performed for cases treated during the last GAS epidemic in 2017-2018. Anamnesis, signs and symptoms, pure-tone audiometry results, treatment, complications, and outcome were collected from medical charts. Patients responded to an otology-specific health-related quality of life survey (EOS-16) 1.5 to 3 years after their treatment. RESULTS The number of GAS infections peaks at approximately 7-year intervals. During 2017 and 2018, altogether 37 patients (29 adults and 8 children) were hospitalized due to GAS AOM/AM. AM was diagnosed in 14 (38%) patients. The disease progression was typically very rapid. At presentation, all patients had severe ear pain, 68% tympanic membrane perforation and discharge, 43% fever, and 43% vertigo. In pure-tone audiometry, there was usually a marked mixed hearing loss at presentation. There was a significant recovery in both air and bone conduction thresholds; the pure tone average improvement from presentation was 32.3 ± 14.8 dB. Rapid strep tests (RST) proved to be more sensitive than bacterial culture in identifying GAS as a cause of AOM/AM. CONCLUSION GAS AOM/AM has a rapid onset. Hearing loss usually includes a sensorineural component, which is usually reversible with adequate treatment. RST seems to be useful in detecting GAS from middle ear discharge. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- Juha T. Laakso
- Department of Otorhinolaryngology—Head and Neck Surgery, Head and Neck CenterHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| | - Valtteri Rissanen
- Department of Otorhinolaryngology—Head and Neck Surgery, Head and Neck CenterHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| | - Eeva Ruotsalainen
- Division of Infectious Diseases, Department of MedicineHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| | - Jarkko Korpi
- Department of Otorhinolaryngology—Head and Neck Surgery, Head and Neck CenterHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| | - Anu Laulajainen‐Hongisto
- Department of Otorhinolaryngology—Head and Neck Surgery, Head and Neck CenterHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| | - Ville Sivonen
- Department of Otorhinolaryngology—Head and Neck Surgery, Head and Neck CenterHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| | - Saku T. Sinkkonen
- Department of Otorhinolaryngology—Head and Neck Surgery, Head and Neck CenterHelsinki University Hospital and University of HelsinkiHelsinkiFinland
| |
Collapse
|
4
|
Sanfins MD, Bertazolli LF, Skarzynski PH, Skarzynska MB, Donadon C, Colella-Santos MF. Otoacoustic Emissions in Children with Long-Term Middle Ear Disease. Life (Basel) 2020; 10:life10110287. [PMID: 33217895 PMCID: PMC7698705 DOI: 10.3390/life10110287] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2020] [Revised: 11/09/2020] [Accepted: 11/12/2020] [Indexed: 11/18/2022] Open
Abstract
Introduction: Otoacoustic emissions (OAEs) evaluate the functional status of the cochlea. Repeated otitis media (OM) can cause changes in the peripheral structures of the auditory system, and, in this way, middle ear infection may irreversibly damage the middle ear, or even the cochlea. Objectives: To analyze the results of transiently evoked otoacoustic emissions (TEOAEs) and distortion product otoacoustic emissions (DPOAEs) in individuals with a history of OM. Method: Participants with 8 to 16 years of schooling were split into two groups: a control group (CG) of 50 subjects who had no history of otological disease and an experimental group (EG) of 50 subjects who had a history of recurrent otitis in childhood and had consequently undergone myringotomy to insert bilateral ventilation tubes. All children underwent basic audiological assessment (tonal audiometry, speech audiometry, and immittance testing) and otoacoustic emission testing (TEOAEs and DPOAEs). Results: There were no significant differences between the groups when audiometrically tested via air and bone conduction. OAEs were found in all CG subjects. For the EG, there were no TEOAE responses in 17 ears and no DPOAEs in nine ears; response amplitudes were lower at all frequencies. The emission level and the signal-to-noise ratio were statistically different between the two groups, and OAEs in the EG were statistically smaller compared to the GC. Conclusion: In the EG, responses were more likely to be absent and were of statistically smaller amplitude compared to the CG. A history of repeated OM apparently interferes with the generation and transmission of TEOAEs and DPOAEs.
Collapse
Affiliation(s)
- Milaine Dominici Sanfins
- Child and Adolescent Heath Program, Faculty of Medical Sciences, State University of Campinas, Campinas, São Paulo 04515-030, Brazil;
- Advanced Electrophysiology and Neuroaudiology Center, Department of Electrophysiology, São Paulo 04515-030, Brazil
- Correspondence: ; Tel.: +55-11-99003-3092
| | - Luisa Frata Bertazolli
- Faculty of Medical Sciences, State University of Campinas, Campinas, São Paulo 04515-030, Brazil;
| | - Piotr H. Skarzynski
- Institute of Physiology and Pathology of Hearing, 00-002 Warsaw, Poland;
- Department of Heart Failure and Cardiac Rehabilitation, Faculty of Medicine, Medical University of Warsaw, 00-002 Warsaw, Poland
- Institute of Sensory Organs, 00-002 Warsaw, Poland;
| | - Magdalena Beata Skarzynska
- Institute of Sensory Organs, 00-002 Warsaw, Poland;
- Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland
- Center of Hearing and Speech, 05-830 Kajetany, Poland
| | - Caroline Donadon
- Child and Adolescent Heath Program, Faculty of Medical Sciences, State University of Campinas, Campinas, São Paulo 04515-030, Brazil;
| | - Maria Francisca Colella-Santos
- Department of Human Development and Rehabilitation (DHDR), Faculty of Medical Sciences, State University of Campinas, Campinas, São Paulo 04515-030, Brazil;
| |
Collapse
|
5
|
Harrison A, Hardison RL, Wallace RM, Fitch J, Heimlich DR, Bryan MO, Dubois L, John-Williams LS, Sebra RP, White P, Moseley MA, Thompson JW, Justice SS, Mason KM. Reprioritization of biofilm metabolism is associated with nutrient adaptation and long-term survival of Haemophilus influenzae. NPJ Biofilms Microbiomes 2019; 5:33. [PMID: 31700653 PMCID: PMC6831627 DOI: 10.1038/s41522-019-0105-6] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2019] [Accepted: 10/03/2019] [Indexed: 01/14/2023] Open
Abstract
Nontypeable Haemophilus influenzae (NTHI) is a human-restricted pathogen with an essential requirement for heme-iron acquisition. We previously demonstrated that microevolution of NTHI promotes stationary phase survival in response to transient heme-iron restriction. In this study, we examine the metabolic contributions to biofilm formation using this evolved NTHI strain, RM33. Quantitative analyses identified 29 proteins, 55 transcripts, and 31 metabolites that significantly changed within in vitro biofilms formed by RM33. The synthesis of all enzymes within the tryptophan and glycogen pathways was significantly increased in biofilms formed by RM33 compared with the parental strain. In addition, increases were observed in metabolite transport, adhesin production, and DNA metabolism. Furthermore, we observed pyruvate as a pivotal point in the metabolic pathways associated with changes in cAMP phosphodiesterase activity during biofilm formation. Taken together, changes in central metabolism combined with increased stores of nutrients may serve to counterbalance nutrient sequestration.
Collapse
Affiliation(s)
- Alistair Harrison
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Microbial Pathogenesis, 700 Children’s Drive, Columbus, OH 43205 USA
| | - Rachael L. Hardison
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Microbial Pathogenesis, 700 Children’s Drive, Columbus, OH 43205 USA
| | - Rachel M. Wallace
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Microbial Pathogenesis, 700 Children’s Drive, Columbus, OH 43205 USA
| | - James Fitch
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, The Steve and Cindy Rasmussen Institute for Genomic Medicine, 575 Children’s Crossroad, Columbus, OH 43215 USA
| | - Derek R. Heimlich
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Microbial Pathogenesis, 700 Children’s Drive, Columbus, OH 43205 USA
| | - Meghan O’ Bryan
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Microbial Pathogenesis, 700 Children’s Drive, Columbus, OH 43205 USA
| | - Laura Dubois
- Duke Proteomics and Metabolomics Core Facility, Duke Center for Genomic and Computational Biology, Duke University, 701 West Main Street, Durham, NC 27701 USA
| | - Lisa St. John-Williams
- Duke Proteomics and Metabolomics Core Facility, Duke Center for Genomic and Computational Biology, Duke University, 701 West Main Street, Durham, NC 27701 USA
| | - Robert P. Sebra
- Icahn School of Medicine at Mount Sinai, Icahn Institute and Department of Genetics & Genomic Sciences, 1 Gustave L. Levy Place, New York, NY 10029 USA
| | - Peter White
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, The Steve and Cindy Rasmussen Institute for Genomic Medicine, 575 Children’s Crossroad, Columbus, OH 43215 USA
| | - M. Arthur Moseley
- Duke Proteomics and Metabolomics Core Facility, Duke Center for Genomic and Computational Biology, Duke University, 701 West Main Street, Durham, NC 27701 USA
| | - J. Will Thompson
- Duke Proteomics and Metabolomics Core Facility, Duke Center for Genomic and Computational Biology, Duke University, 701 West Main Street, Durham, NC 27701 USA
| | - Sheryl S. Justice
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Microbial Pathogenesis, 700 Children’s Drive, Columbus, OH 43205 USA
- Infectious Diseases Institute, The Ohio State University College of Medicine, 700 Children’s Drive, Columbus, OH 43205 USA
| | - Kevin M. Mason
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital, Center for Microbial Pathogenesis, 700 Children’s Drive, Columbus, OH 43205 USA
- Infectious Diseases Institute, The Ohio State University College of Medicine, 700 Children’s Drive, Columbus, OH 43205 USA
| |
Collapse
|